Loading
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Latest filing published 09 Jun 2026 for Arcutis Biotherapeutics, Inc.. Read the official filing
Filing timeline
BuySaleAmit Munshi
Insider track record
Disclosed buys
6
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Amit Munshi: trading record in brief
Amit Munshi is a declared insider at 4 companies (chief executive); the most frequent names are Arena Pharmaceuticals Inc, Inhibikase Therapeutics, Inc. and Zura Bio Ltd. Over a trading history stretching from 10 August 2021 to 5 June 2026, the count stands at 13 filings.
The open-market record is one-sided, with 6 purchases worth €1.5M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 5 share grants.
A typical purchase (the median) is worth €254k. 2 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 9 June 2026: a share grant, in Arcutis Biotherapeutics, Inc. The last purchase on record was published on 23 October 2024, which is 725 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Amit Munshi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
5,778 shares0Common StockSEC:0001628280-26-042041:0
19,089 shares0Common StockSEC:0001193125-26-068063:0
2,021 shares0Common StockSEC:0001628280-25-055927:0
57,265 shares0Common StockSEC:0001193125-25-191463:0
365,000 shares@ US$1.37100.0% of flowCommon StockSEC:0000950170-24-116780:0
Canonical exit: 19 Jan 2025 (T+90)
159,744 shares@ US$3.1333.4% of flowClass A ordinary sharesSEC:0001415889-24-023028:0
159,744 shares@ US$3.1333.4% of flowClass A ordinary sharesSEC:0001415889-24-011480:0
Canonical exit: 21 Jul 2024 (T+90)
117,647 shares@ US$4.2533.2% of flowClass A Ordinary SharesSEC:0001104659-23-068206:0
Canonical exit: 3 Sept 2023 (T+90)
10,500 shares@ US$98.5188.1% of flowCommon StockSEC:0001628280-22-005889:0
85,847 shares0Common StockSEC:0001628280-22-000341:0
1,000 shares@ US$48.193.8% of flowCommon StockSEC:0001628280-21-017167:0
Canonical exit: 14 Nov 2021 (T+90)
1,000 shares@ US$50.414.0% of flowCommon StockSEC:0001628280-21-016916:0
Canonical exit: 10 Nov 2021 (T+90)
1,000 shares@ US$52.9154.2% of flowCommon StockSEC:0001628280-21-016504:0
Canonical exit: 8 Nov 2021 (T+90)
13 of 13 declarations
